Maternal serum Apelin 13 and APLN gene promoter variant -1860T > C in preeclampsia

References

• ACOG Practice Bulletin. NUMBER 202. 2019. Obstet Gynecol. 2019;133(1):e1–e25.
   Web of Science ®Google Scholar
• Magee LA, Sharma S, Nathan HL, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria. PLoS Med. 2019;16(4):e1002783.
   PubMed Web of Science ®Google Scholar
• Dekker G, Sukcharoen N. Etiology of preeclampsia: an update. J Med Assoc Thai. 2004;87(3):S96–S103.
   PubMedGoogle Scholar
• Vanishree CD, Dayanand PP. Kotur Is xanthine oxidase, a marker in pre-eclampsia? A case-control study. J Clin Diagn Res. 2015;9(10):BC01–BC03.
   Google Scholar
• Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013; 71(1):S18–S25.
   PubMedGoogle Scholar
• Gürlek B, Yılmaz A, Murtaza E, Durakoglugil ME, et al. Evaluation of serum apelin-13 and apelin-36 concentrations in preeclamptic pregnancies. J Obstet Gynaecol Res. 2020;46(1):58–65.
   PubMed Web of Science ®Google Scholar
• Daskalakis G. Papapanaglotou Serum markers for the prediction of preeclampsia. J Neurol Neurophysiol. 2015;6(1):1–9.
   PubMedGoogle Scholar
• Kjell Haram K, Jan Helge M, Bálint N. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy. 2014;2014:910751.
   PubMedGoogle Scholar
• Buurma AJ, Turner RJ, Driessen JH, et al. Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update. 2013;19(3):289–303.
   PubMed Web of Science ®Google Scholar
• Gandham R, Sumathi ME, Dayanand CD, et al. Apelin and its receptor: an overview. J Clin Diagn Res. 2019;13(16):12930.
   Google Scholar
• Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun. 2004;325(2):395–400.
   PubMed Web of Science ®Google Scholar
• Jin W, Su X, Xu M, et al. Interactive association of five candidate polymorphisms in Apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients. PLoS One. 2012;7(12):e51123.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu C, Cheng C, et al. Effects of Apelin peptides on diabetic complications. Curr Protein Pept Sci. 2018;19(2):179–189.
   PubMed Web of Science ®Google Scholar
• Bortoff KD, Qiu C, Runyon S, et al. Decreased maternal plasma apelin concentrations in preeclampsia. Hypertens Pregnancy. 2012;31(4):398–404.
   PubMed Web of Science ®Google Scholar
• Cox CM, D’Agostino SL, Miller MK, et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177–189.
   PubMed Web of Science ®Google Scholar
• Kasai A, Shintani N, Kato H, et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28(10):1717–1722.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kihara M, Ishida J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2006;26(6):1267–1272.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept. 2001;99(2–3):87–92.
   PubMed Web of Science ®Google Scholar
• Leeper NJ, Tedesco MM, Kojima Y, et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 2009;296(5):H1329–35.
   PubMed Web of Science ®Google Scholar
• Kidoya H, Naito H, Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood. 2010;115(15):3166–3174.
   PubMed Web of Science ®Google Scholar
• Inuzuka H, Nishizawa H, Inagaki A, et al. Decreased expression of apelin in placentas from severe preeclampsia patients. Hypertens Pregnancy. 2013;32(4):410–421.
   PubMed Web of Science ®Google Scholar
• Simsek Y, Celik O, Yilmaz E, et al. Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med. 2012; 25(9):1705–1708.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of ‘the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. ObstetGynecol. 2013; 122:1122–1131.
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
   PubMed Web of Science ®Google Scholar
• Akcılar R, Yümün G, Bayat Z, et al. Characterization of the apelin -1860T > C polymorphism in Turkish coronary artery disease patients and healthy individuals. Int J Physiol Pathophysiol Pharmacol. 2015;7(4):165–171.
   PubMedGoogle Scholar
• Lee PY, Costumbrado J, Hsu CY, et al. Agarose gel electrophoresis for the separation of DNA fragments. J Vis Exp. 2012;(62):3923.
   Google Scholar
• Yamaleyeva LM, Chappell M, Brosnihan KB, et al. Down-regulation of apelin in the human placental chorionic villi from preeclamptic pregnancies. Am J Physiol Endocrinol Metab. 2015;309(10):E852–60.
   PubMed Web of Science ®Google Scholar
• Li WW, Niu WQ, Zhang Y, et al. Family-based analysis of apelin and AGTRL1 gene polymorphisms with hypertension in Han Chinese. J Hypertens. 2009;27(6):1194–1201.
   PubMed Web of Science ®Google Scholar
• Jia J, Men C, Tang KT, et al. Apelin polymorphism predicts blood pressure response to losartan in older Chinese women with essential hypertension. Genet Mol Res. 2015;14(2):6561–6568.
   PubMed Web of Science ®Google Scholar
• Anton L, Brosnihan KB. Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis. 2008;2(5):349–362.
   PubMedGoogle Scholar
• Siddiquee K, Hampton J, Khan S, et al. Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. J Hypertens. 2011;29(4):724–731.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhu W, Zhang P, et al. Apelin-13 stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in myocardial microvascular endothelial cells. Mol Med Rep. 2014;9(5):1590–1596.
   PubMed Web of Science ®Google Scholar
• Jia YX, Lu ZF, Zhang J, et al. Apelin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Peptides. 2007;28(10):2023–2029.
   PubMed Web of Science ®Google Scholar
• Cobellis L, De Falco M, Mastrogiacomo A, et al. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol Histopathol. 2007;22(1):1–8.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642–649.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Kong D, et al. Apelin as a novel drug for treating preeclampsia. Exp Ther Med. 2017;14(6):5917–5923.
   PubMed Web of Science ®Google Scholar
• Kalea AZ, Batlle D. Apelin and ACE2 in cardiovascular disease. Curr Opin Investig Drugs. 2010;11(3):273–282.
   PubMedGoogle Scholar
• Goetze JP, Rehfeld JF, Carlsen J, et al. Apelin: a new plasma marker of cardiopulmonary disease. RegulPept. 2006;133(1–3):134–138.
   PubMedGoogle Scholar
• Wang W, McKinnie SM, Farhan M, et al. Angiotensin-converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and Apelin-17: physiological effects in the cardiovascular system. Hypertension. 2016;68(2):365–377.
   PubMed Web of Science ®Google Scholar
• Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019;105(16):1273–1278.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Saito S, Higuma T, et al. Plasma apelin level is decreased in patients with coronary artery disease. Hirosaki Med J. 2010; 61:58–64.
   Google Scholar
• Bilik MZ, Kaplan İ, Yıldız A, et al. Apelin levels in isolated coronary artery ectasia. Korean Circ J. 2015;45(5):386–390.
   PubMed Web of Science ®Google Scholar
• Chong KS, Gardner RS, Morton JJ, et al. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail. 2006;8(4):355–360.
   PubMed Web of Science ®Google Scholar
• Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis. 2008;2(4):249–259.
   PubMedGoogle Scholar